Population and public health are in the midst of an artificial intelligence revolution capable of
radically altering existing models of care delivery and practice. Just as AI seeks to mirror …

Acromegaly is typically caused by a growth hormone–secreting pituitary adenoma, driving
excess secretion of insulin-like growth factor 1. Acromegaly may result in a variety of …

The relationship between face and disease has been discussed from thousands years ago,
which leads to the occurrence of facial diagnosis. The objective here is to explore the …

Acromegaly is characterized by increased release of growth hormone and, consequently,
insulin-like growth factor I (IGF1), most often by a pituitary adenoma. Prolonged exposure to …

Artificial intelligence (AI) has illuminated a clear path towards an evolving health-care
system replete with enhanced precision and computing capabilities. Medical imaging …

Introduction Acromegaly is a rare, insidious disease resulting from the overproduction of
growth hormone (GH) and insulin-like growth factor 1 (IGF-1), and is associated with a range …

Acromegaly is caused by excess growth hormone (GH) secretion emanating from a
somatotroph adenoma. High GH and Insulin-like growth factor-1 (IGF-1) levels lead to acral …

Diseases not only manifest as internal structural and functional abnormalities, but also have
facial characteristics and appearance deformities. Specific facial phenotypes are potential …

Acromegaly and gigantism are due to excess GH production, usually as a result of a pituitary
adenoma. The incidence of acromegaly is 5 cases per million per year and the prevalence is …

Background Automatic early detection of acromegaly is theoretically possible from facial
photographs, which can lessen the prevalence and increase the cure probability. Methods In …